Vaxart, Inc. Notes Payable, Current
Vaxart, Inc. (VXRT) had Notes Payable, Current of $102.00 thousand as of 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:NotesPayableCurrent · last filed 2018-11-13
- 2018-09-30: Notes Payable, Current $102.00K.
- 2018-06-30: Notes Payable, Current $153.00K.
- 2018-03-31: Notes Payable, Current $214.00K.
- 2017-12-31: Notes Payable, Current $300.00K.
| Period end | Notes Payable, Current |
|---|---|
| 2018-09-30 | $102.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $153.00K 10-Q · filed 2018-08-10 |
| 2018-03-31 | $214.00K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $300.00K 10-Q · filed 2018-02-06 |
| 2017-09-30 | $200.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $200.00K 10-Q · filed 2018-02-06 |
| 2017-03-31 | $300.00K 10-Q · filed 2017-05-08 |
| 2016-12-31 | $300.00K 10-Q · filed 2017-02-06 |
| 2016-09-30 | $400.00K 10-Q · filed 2016-11-08 |
| 2016-06-30 | $400.00K 10-K · filed 2017-09-01 |
| 2016-03-31 | $500.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $400.00K 10-Q · filed 2016-02-08 |
| 2015-09-30 | $200.00K 10-Q · filed 2015-11-06 |
| 2015-06-30 | $200.00K 10-K · filed 2016-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |